Patents Assigned to Novarits AG
  • Purine derivatives and their use in the treatment of disease
    Patent number: 9334271
    Abstract: The invention relates to PI3K inhibitors of the formula (I)• in which all of the variables are as defined in the specification, to their preparation, to their medical use, in particular to their use in the treatment of cancer and neurodegenerative disorders, and to medicaments comprising them.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: May 10, 2016
    Assignee: Novarits AG
    Inventors: Emmanuelle Briard, Pascal Furet, Andreas Lerchner, Peter Meier, Branko Radetich, David Andrew Sandham, Yanyi Zhu
  • Heteroatoms-containing tricyclic compounds
    Patent number: 7514554
    Abstract: A process for the production of 33-Epi-33-chloro-FR 520 in one step from FR520 wherein protecting groups are avoided.
    Type: Grant
    Filed: October 10, 2005
    Date of Patent: April 7, 2009
    Assignee: Novarits AG
    Inventors: Maximilian Grassberger, Amarylla Horvath